Initially conceived in response to the low-temperature cold chain demands of COVID vaccines, the cylindrical device is suitable for the transfer of any temperature-sensitive pharmaceutical products. It uses a feedback loop of cold air to maintain a consistent low temperature and can hold a variety of vaccines and medical supplies across three different segments.
The storage device also features a digital data log for real-time tracking of temperature and location, as well as a self-closing lid and LED indicators to alert users to any problems. According to the MTC, a prototype built by its team of engineers and designers has the potential to holds temperature within range for up to six hours under battery power.
“This product supports not only the ongoing pandemic, but also provides a solution for any temperature-critical transportable pharma goods,” said MTC associate director, Danny McGee. “The product is a fine example of how innovation can have a direct and beneficial impact on society.”
When first researching the concept in July 2020, the MTC team found that some 60 per cent of wasted vaccines in the UK were as a result of fridge-related failures. With the COVID pandemic in full swing at the time and vaccines the best chanced of ending it, the team realised that millions of vaccines could potentially be wasted if the infrastructure remained the same.
“Solving issues with vaccination distribution and storage was identified as the most impactful way the MTC could help in the fight against Covid-19,” said MTC design engineer Harmail Sandhu.
The hard work of the team has resulted in a successful outcome with the potential to make more vaccines available throughout the world by reducing wastage,” he said.